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ABSTRACT 
The article presents a historical background on the use of tear 
gases in war and civilian riot control activity. The classification of 
chemical compounds used as irritants, and their structure - activity 
relationship established through different studies has been examined. 
A review of toxic effects which is different from irritancy of Adamsite, 
o- chloroacetophenorie (CN), o-chlorobenzylidene malononitrile (CS) 
and Dibenz (b,f), [I, 41 - oxazepine (CR) has been presented. 
1. INTRODUCTION 
Tear gas compounds are used by Defence services in many countries and 
law-enforcing agencies in all the countries of the world. These compounds bring about 
temporary incapacitation by the imtation of eyes, nose, respiratory tract and skin 
with consequent production of profuse tears and mucous. The effect last a little longer 
than the duration of exposure. 
Toxicity studies of tear-gases are important from two view points - (a) from the 
occupational health view point to assess the risk to all involved in production and 
handling of tear gas munitions and (b) to those who are occasionally exposed to it in 
training manoeuvres and general public in actual use. 
All the tear gas compounds in ldw concentrations produce instantaneous 
physiological response and activation of the' lacrimal glands. Some of these have more 
severe and punishing physiological effects, like pain in the eyes accompanied by 
involuntary reflexes and secretion of viscous fluids. The mucous membrane of the 
nose, throat and lungs are particularly susceptible. In low concentrations, short 
exposures causes only irritation of the nose and throat, producing sneezing, coughing, 
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lacrimation, viscous discharge from the nose and severe headache. In higher 
concentrations or prolonged exposure the symptoms increase in severity accompanied 
by an acute pain in the chest, difficulty in breathing, cramps, nausea, vomiting and 
stinging sensation of the skin. 
Immediately after the out break of the first World War, use of eye irritants were 
reported to by the Germans and the French. These were well known organic 
compounds, synthesised in the laboratory during the preceeding century and hardly 
has been exploited industrially. The first use of tear gas during civil disturbances has 
been attributed to the Paris Police, who used 'Hand bombs' filled with 
ethylbromoacetatel (EBA) in 1912. A rapid expansion in the use of chemicals for 
peace keeping occurred in the U.S. following a marked increase in the crime rate in 
the 20s. Since then, the use of tear gases to restore law and' order during violent 
demonstrations have increased on world wide scale. w- Chloroacetophenone (CAP 
or CN) and Diphenylaminechloroarsine ( ~ d k s i t e  or DM) were the chemicals 
favoured upto the 1940's, and CAP is still in use in our country.' Then 
o-chlorobenzalmalononitrile (CS) was introduced by the British in the 50's initially 
in Malaya for fighting the Communists in the dense forests. This is in use with most 
of the police forces abroad. p e  more recent innovation in the 70's is Dibenz (b,f), 
[I, 41 - oxazepine (CR) a British discovery, is slowly getting acceptance abroad as a 
riot control agent. 
2. CLASSIFICATION 
~ i x o n , ~  Dixon and ~eedham? ~ackworth' and ~ a c @ '  have proposed the 
following classification on the basis of imtant chemical's interaction with SH groups 
of the receptor protein associated with the nerve ending. w-Chloroacetophenone 
initially was utilised to classify 'thio-enzyme' depending on whether or not these are 
inhibited.' A similar tkhaviour with vesicant has already been reported earlier by 
peters9 et al. 1963. 
The compounds used so far are listed in Table 1 along with their toxicity data. 
They can be grouped as given follows : 
Group I : Compounds possessing a positive halogen. 
Group I1 : Compounds possessing ethylenic double bond. 
Group I11 : Compounds possessing >C=N linkage. 
Group IV : Compounds possessiong trivalent arsenic. 
The structural formulae and physical characteristic of some of these tear gas 
compounds are given in Table 1. 
3. STRUCTURE-ACTIVITY RELATIONSHIP OF IRRITANTS 
3.1 Group I : Compounds with a Positive Halogen 
The main characteristic of halogenated compounds is the positive halogen mom 
electron displacement under the influence of neighbouring groups, such as, carbonyl 
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Table 1. Structural formulae and physical characteristic of tear gas compounds 
S. No Compounds Structural Code Specific Minimum Minimum 
formulae gravity Lacrimatory Lethal 
Conc. Conc. 
(mgfl.1 (mgn.1 




IW2COOC,H, EIA 1.80 
CZC%COCH3 A-Stoff 1,.80 
IC%COCH3 1.43 
5 Bromomethylethyl ketone BrCH,COC% CH; 
6. Benzyliodide . C6H,CH21 
Cyanogen bromide CNBr 
Phenyl Carbylamine C6H,CNC3 
chloride 
9. Bromobenzyl cyanide C'H4(CN)Br CA or BBC 
10. Bromoacetone BrC%COCH, BA 1 .60 
11, Benzyl bromide C6H,C%Br 1.49 
12. Chloropicrin m3N0z PS 1.66 
13. Xylyl bromide C,H4(CH2),Br 'T-Stoff 1.40 
14, o-Chloroacetophenone ClC%COC,H, CNICAP 1.32 
15. Acrolein CH,=CH-CHO - 0.84 0.0070 0.35 
16 o-Chlorobenzylidene- C6H4(Cl)CH= (CN): CS 
malononitrile 
17. Diphenyl chloroarsine (C6H,),AsCI D A 
18. Diphenyl cyanoarsine (C,HJ,AsCN DC 
. 
19. Adamsite C6H4 
\ m/d cP, DM 
20. Dibenz (b,f) [l,4]- C& 'O' cp, CR 72°C 
oxazepine \CH=N/ 
. - - 
in esters, ketones, aldehyde, amide etc. 
RSH + RCOCH2C1 R-S-CH2-C-R + HCl 
b 
Receptor Protein 
The chemicals of group I have not been extensively tested on the animals except 
chloroacetophenone (CN). ~oncrief' ' has given the general rules to correlate the 
structure of these compounds with their biological activity : 
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(i) If the halogen is present.in the /?-position, sensory irritation is more intense 
than in the a-position e.g. ethyl p-chloropropionate > ethyl a-chloropropionate. 
(ii) One halogen atom often confers more lacrimatory properties than 2 or 3-halogen 
atoms. Monochloromethyl chloroformate is predominantly lacrimator but 
trichloromethyl chloroformate is not a lacrimator but an asphyxiant. 
(iii) Activity also depends on the atomic weight of the halogen atom in the order 
F< C1< BrC I; thus bromoacetone is 18 times more imtating than chloroacetone; 
benzyl iodide is a more powerful irritant than the corresponding 
bromo-derivatives. 
(iv) In aromatic series, chlorine in a side chain increases imtancy but not in the 
nucleus e.g. o-chloroacetophenone is a very powerful lacrimator, while 
2-chloroacetophenone a non-imtant. Xylyl bromide is a lacrimator but 
bromoxylene is not. Symmetrical compounds are usually more lacrimatory than 
unsymmetrical. 
(v) The introduction of nitro group into the molecule has been found to increase 
lacrirnatory properties. 
Amongst the intensively active compounds in Group I used as tear gas compounds 
are the compounds having chlorine or cyanide in the side chain. 
ICNI 
3.2 Group I1 : Compounds with Ethylenic Bonds 
The compounds of the group I1 contain ethylenic double bond, which is polarised 
in the presence of electron withdrawing groups. These groups can be ester carbonyl, 
keto carbonyl, amide, nitrile, nitro or halogens. 
Tarantino and Sass", l2 have investigated the reactivity of Group I1 compounds 
towards -SH groups using diethylaminoethyl mercaptan (DEAEM) as substrate. Using 
fall in respiratory rates as an index in mice, a series of benzalmalononitriles were 
evaluated as sensory imtants.13 A few rules on the molecular feature of these 
compounds needed for imtancy could be worked out. The general structure of this 
series is 
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(i) Where R, is H and R, is Aryl or Alkyl, Nitroalkyl. The compounds having nitro 
group are more imtant. 
(ii) R, and R, are essentially those capable of polarizing the adjacent double bond 
so that nucleophilic reagents can react easily. 
(iii) R, must be H on a a-carbon atom, as it is a prime requirement of this series 
of compounds. Since replacement of H by any group, such as, phenyl, CH, or 
CN yield completely inactive compounds. 
(iv) The substitution on benzene ring in R, by halogen will increase the irritancy of 
Benzalmalononitriles. 
cC 
- cN - R-CH-C _ RSH+ RCH= C 
CN - 1 1  RS H 
3.3 Group III - Compounds Possessing > C=N ,inkage 
Compounds containing > C=N are very potent sensory imtants14 but there is very 
little information on any correlation of activity with structure. These compounds are 
more susceptible to nucleophilic attack in presence of electron withdrawing group 
attached to the phenyl group e.g., Dibenz (b, f), [I, 41 -oxazepine (CR) and 
halogenated oximes. The 11-methyl derivative of Dibenz (b, f), [I, 41 -0xazepine is 
a non-irritant, whereas %methyl and %methyl retained some imtancy, but both are 
less potent" than CR. 
3.4 Group IV - Compounds with Trivalent Arsenic 
By the reaction of organic trivalent arsenicals with SH group of the receptor 
proteins the mercaptides are formed e.g. DM, DA and DC. 
Cl SH 
RSH + HCI 
Infltlence of various halogen atoms on the physiological effect in case of organic 
compounds of arsenic is the reverse of that found for the eye imtants. The effect is 
in the order I < Br < Cl, the presence of a CN group increases the imtant effect 
and the toxicity. Thus diphenyl cyanoarsine (DC) is more toxic than diphenyl 
chloroarsine (DA). 
'64  - A S ,  (DA) Lower threshold lo4 mg/l 
CsH* - 
CdNs - 
Ca4 ASCN ( D o  Lower threshold mgA 
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4. TOXICITY STUDIES OF IRRITANTS 
4.1 Adamsite (DM, Diphenylaminechloroarsine) 
Adamsite was the American answer to the German tear gas DA (Diphenyl 
chloroarsine), first prepared by Major Rodger Adams in 1918 (and called Adamsite. 
after him) by heating arsenic (111) chloride with diphenylamine or arsenic (111) oxide 
with diphenyl ammonium chloride.16 
In pure state, it is bright canary-yellow crystalline solid, sp. gr. 1.65 and m.p. 
195°C. DM is practically odourless with low vapour press-. When it is dispersed by 
burning type munitions, it forms a yellow particulate cloud that has characteristic 
'smoky odour'. DM is stable on storage and is not affected by the water or moisture 
in solid state. However, in aerosol form it is hydrolysed slowly by water or moisture 
to hydrogen chloride and diphenyl amino arsenious oxide. The oxide is more 
poisonous. When DM is used during riots or for training purposes, the oxide is capable 
of poisoning open foodstuffs and water supplies. It has a persistency less than 10 
minutes. 
Exposure to DM produces acute pain in the nose and paranasal air sinuses with 
a burning sensation in the throat, tightness and pain in the chest, accompanied by 
sneezing nolent coughing, eye pain, lacrimation, blepharospasm, rhinorrhoea, excess 
salivation, nausea and vomiting. There is usually a delay of some minutes between 
the exposure and onset of symptoms; recovery is normally complete within 1 to 2 
hours after exposure. Compared with CN and CS, DM could be absorbed before 
warning symptoms occur." It irritates the eyes and mucous membrane after one to 
two minutes in concentration around 0.00038 mg/l of air, producing sneezing and 
coughing. Highest intensity of imtation is around 0.0005 mg/l. The concentration 0.65 
mg/l is reported to be lethal after about thirty minutes and 3.0 mg/l after 10 minutes. 
Death from severe pulmonary damage on exposure to higher concentrations of DM 
has been reported.'' Heavy exposure to DM may produce necrosis of corneal 
epithelium.19 In humans, acute inhalation dosez0 L (Ct)w, estimated is 11000-25000 
mg~minlm.~ 
4.2 oChloroacetophenone (CN) 
o-Chloroacetophenone or CN was discovered in 1871 by the German Chemist 
~ r a e b e ~ '  and was introduced in the military during first world war. CN can be prepared 
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Table 2. Wysiaxbemical properties and acute mammalian toddty data of commonly used tear gases- 
Structural 1Gchloro 1-chloro Z-chloro Dibenz (b,f) 
formula 5,lOdhydro acetophenone benzylidene [I ,4] -0xazepine 
phenarsazine malononitrile 
2. Physical state Green-yellow White solid White solid Pale-yellow solid 
solid 
3. Melting point(T) 195 59 94 72 
4 Mol. weight 27l.5 154.5 188.6 195.1 
5 Vapour pressure 2 x ld" 5.4 x I@' 3.4 r lw5 5.9 x lc5 
at UpC (mm Hg) 
6. Water solubility Insoluble 4.4 x lw3 2.0 x 104 3.5 x 104 
at 20°C (molest 
litre) 
7 TC,for aerosol 0.5 0.4 23 x lU3 2 x lU3 
(mglm3) 
respiration 
8 Acute mammalian 
toxicity : Rat 
(i) LD,mgkg 
(a) Intravenous ' 26 35-41 28-35 68 
(b) Intraperitoneal 164 %56 48-66 166-817 
(c) Oral 563 52-258 178-1366 13000' 
Ci) L(W, 
(a) Inhalation: 
Pure material 300-12710 3700-18800 88480 4WXX) 
(b) Inhalation: 
Smoke 'Q217 23330 68000 139000 
Pravin, K. et al. (1986), Report on toxicity93 of CR 
** B.Ballantyne, Report on riot control agents, Special &ticlew (1978). 
industrially by two methods, by chlorination of acetophenone or by Friedel and Craft's 
reaction from benzene and chloroacetyl chloride. It is a colourless crystailine substance 
which melts at 57-58"C, the volatility at 20°C is 0.11 m a .  The vapours are 5.2 times 
heavier than air and does not decompose at its own boiling point (247°C). CN starts 
decomposing 'at  450°C and decomposesU completely above 1000°C. Other 
physico-chemical properties and acute mammalian toxicity of this compound is given 
in Table 2. CN is an alkylating agent which reacts directly with nucleophilic compounds 
by S N ~  reaction. Toxic effects of CN are probably due to alkylation of -SH containing 
e n ~ ~ m e s . ~ ~ . ~ ~  The harassing effects of CN occur at concentration around 10 m g ~ m . ~  
First symptoms are lacrimation and salivation followed by burning or stinging 
sensations in the throat, eyes, and nose accompanied by rhinorrhoea, constriction 
sensation in the chest and difficulty in breathing. CN by all the routes of administration 
is significantly more toxic than CS or CR (Table 2) but less toxic than DM." The 
chemical injuries to eye occur more with CN solution than powder. CN may also 
cause primary contact dermatitis, erythema, oedema, vesication, purpura and 
necrosis.2G29 Allergic contact dermatitis has also been described and confirmed by 
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conventional skin patch test in Most of the sign and symptoms disappkar 
within 20 minutes except conjuctivitis which may persists for 24 hours. 
The maximum safe inhaled dose32 of CN for man is 500 mg/~nin/rn.~ Human lethal 
acute inhalation were estimated to be 8500-25000 mg/~nin/m.~ ~cNamara" 
et al. estimated the L(Ct), for CN to man as 7000 mglmin/m3 for pure aerosol and 
14000 mg/min/m3 for commercial grenade. Five deaths have been reported with the 
high inhalation dose by lung damage following the use of CN grenades in confined 
spaces. 353 
In the United States, military establishments were using various liquid 
chloroacetophenone formulations which were discontinued due to the long lasting 
cumulative effects. 
4.3 ~Chlorobenzylidene Malononitrile (CS) 
Synthesis of o -chlorobenzylidene malononitrile (CS) was first reported by Corson 
and ~ t o u ~ h t o n ~ ~  and was introduced as riot control agent in 1958. 2-Chlorobenzylidene 
malononitrile can be prepared by the condensation of 2-chlorobenzaldehyde and. 
malononitrile in presence of pyridine as base. 
It is a white crystalline solid, ten times more potentw1 than CN (Table 2). To 
produce immediate effects on the eyes and respiratory tract, 4 mg/m3 concentration 
is sufficient.17," Exposure to CS results in immediate burning sensation in the eye, 
accompanied by copious flow of tears and involuntary closing oi  eyes. Irritation of 
the respiratory tract results in sneezing, tightness of the chest with difficulty in breathing 
and coughing. In high concentrations CS causes nausea and vomiting. In addition 
there is severe stinging sensations on the moist surfaces of the exposed skin, which 
may be followed by erythema." Recovery is usually complete within 30 minutes after 
the exposure but a few signs and symptoms may persist little longer.44 Eye damage 
with CS seems to be significantly4094u7 lower than with CN. On the human eye CS 
grenade smoke cause only irritation.47 punte4' et al. studied the effect of CS on human 
volunteers at elevated temperature and humidity and found that tolerance to CS could 
be reduced by exercise, hyperventilation, elevated temperature and humidity. If the 
whole body is drenched with a solution of CS in concentration range 0.0001-0.005 per 
cent (10-50 pg/ml) causes almost immediate eye discomfort, blephorospasm and excess 
la~r imat ion.~~ The severity and duration of the cutaneous imtant effect of solution of 
CS are less than that caused by a dilute s o l u t i ~ n ~ ~ ~ '  of CR. CS is not teratogenic in 
animal ~tudies'~.'~ and epidemiological studies.39 It is also not embryotoxic and has 
no adverse effects on human pregnancy.54 The minimum exposure dose of CS causing 
fatal lung damage after acute exposure or chronic exposure is hundred times more 
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than the intolerable concentration dose in man39.55.56 it can be said that safety index 
is very high. The estimate of human acute lethal inhalation dose33 vary between 25000 
and 15000 mg/min/m.3 No deaths are reported with CS smoke, the accumulation of 
an exposure dose of pyrotechnically generated CS smoke of the order of 5000 
mg/min/m3 constitute virtually negligible risk to life.57 In those with chronic bronchitis 
there is a possibility of a superimposed acute bronchitis or b ronch~~neumonia .~~  
Likewise CS could trigger asthmatic attack in susceptible persons. Exposure to CS 
aerosol under controlled conditions results in a transient rise in blood pressure and 
heart rate, but no significant change in the electrocardiogram, liver function tests, 
peripheral blood haematology or lymphocyte chromosome morphology.57358 There is 
no significant change in the-chest radiograph, peak air flow, tidal volume and vital 
capacity.s9 Pulmonary gas transfer and alveolar volume are unchanged,* but a 
reduction in exercise ventilation volume occurs6' possibly due to stimulation of 
respiratory tract  receptor^.^^ Primary contact dermatitis and allergic contact dermatitis 
from CS are less   eve re^^-^' than from CN, and is less potent as skin ~ensi t izer~~ than
CN. The acute exposure of CS causes significant cytochemical changes, both in the 
cortical and medullary regions of adrenal glands of rats in higher The dose 
dependent inhibition of cytochrome oxidase, sodium pyruvate (pyruvate 
dehydrogenase complex) and of LDH, SDH, MDH and GDH in the brain of rats in 
vivo were shown by ~ u b e @  et al. The immuno-suppresive properties in mice were 
reported by ~ a ~ a r k a t t i ~ ' , ~ '  et al.
Both CS and CN are SN, alkylating agents that react with sulphydryl (SH) groups 
of receptor proteins. CS reversibly inhibits lactate dehydrogenase, SH dependent 
enzyme. The symptoms and time of onset of poisoning by CS and other malononitriles 
are similar in equimolar dose72 and urinary thiocyanate excretion is elevated in animals 
exposed to CS. The lethal toxicity of inhaled CS is by lung damage leading asphyxia 
and circulatory failure or from bronchopneumonia secondary to respiratory tract 
damage.73 In high dosage toxicity is due to the cyhogenic property of the CS like that 
of other rnal~nonitr i les.~~'~~ The amount of cyanide is negligible from an exposure 
dose of CS which an individual can tolerate. If both the CN groups were converted 
to cyanide (there is in vivo evidence that only one of the group is effectively cyanogenic) 
the total amount of cyanide obtained from 1.05 p mole of CS was equivalent to the 
cyanide content of two 30 ml puffs from a cigarette. A man exposed to atmospheric 
concentrations of CS in the range 0.02-6.4 mg/m3 for 0.05-13 minutes (tolerance time) 
did not have increased plasma or urinary thi~cyanate.'~ 
The major metabolites of CS are Zchlorobenzyl malononitrile (CSH), 
o-chlorobenzaldehyde (OCB), o-chlorohippuric acid and t h i o ~ ~ a n a t e . ~ - ' ~  The 
reduction of the benzylidene double bond in CS to CSH, is catalysed by NADPH 
dependent erythrocyte enzyme. CS and their metabolites can be detected after 
respiratory exposure for a long time and CS, CSH, and OCB have half lives of 5.5, 
9.5 and 4.5 seconds.80 
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4.4 Dibenz (b,i), [1,4] - Oxazepine (CR) 
Dibenz (b,f), [1,4] - oxazepine (CR) was first synthesised by ~iggnbottom" et 
al. by Bischler-Napieralski type ring closure of o-acylaminodiphenyl ether with PPA. 
The synthesis of CR was further modified by various workers.82a At DRDE, Gwalior, 
CR was synthesised by a 2-step procedure involving the forination of Schiff s base by 
the condensation of salicylaldehyde and orthochloroaniline followed by the ring closure 
of sodium salt of Schiffs base in the of DMF. 
It is a yellow crystalline solid, poorly soluble in water (3.5 x lo4 mole per litre) 
but highly soluble in almost all the organic solvents. CR is less toxic8& than CN, CS 
and DM. The comparative physico-chemical properties and acute mammalian toxicity 
data of CN, CS, DM and CR are given in the Table 2. Because of its chemical stability, 
CR could be used in either aerosol or in the solution form in polyethylene glycol 
(PEG-300) or dipropylene glycol monoethyl ether (DPM). 
The effects produced by solution of CR depend ori concentration, formulation, 
the site and extent of body contamination.-The parts of the body affected by CR 
solution are eyes, skin, mouth and nasal cavity. In the concentration range 0.01-0.1 
per cent (0.1-1 mg CRIml) results in immediate eye pain, blepharospasm and 
lacrymation, which persists for 15-20 minutes and oedema of lid margins for 3-6 hours. 
The potential eye damage with CR is significantly less than CN, CS or DM. If the 
whole body is drenched with a solution of CR (wlv 0.001-0.00025 per cent), it causes 
irritating effects on the eyes which persists for 3 to 5 minutes. A sharp rise in intraocular 
pressure is usually present during the acute phase. The lowest concentration of CR 
in solution causing detectable transient keratitis in animals9 is 5 per cent. CR effects 
persist for 20 minutes, but readily reactivated on washing with water.90991 CR causes 
an erythema, restricted to contaminated area of skin which usually subsides within 
one hour. CR does not induce inflammatory infiltration, vesication or contact 
sensitisation and does not delay the healing of skin injuries. Daily application of CR 
solution to skin of mice over 3 months did not lead to any local or systemic long term 
consequences. 
CR causes most unpleasant taste and burning sensations in mouth, accompanied 
by profuse salivation but there is no serious toxicological hazards. The effect may 
persist for 10-15 minutes. The splash contamination of the nasal cavity causes nasal 
irritation, a stuffy sensation and rhinorrhoea. 
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CR is far less toxic than other known imtants, so it has not been possible to 
obtain an L(Ct), values for the pure aerosol of CR. The pyrotechnic smoke 
composition shows acute single dose inhalation toxicity 2-4.6 times less than that of 
CS containing smoke.25 The human acute L(Ct), for pyrotechnically generated CR 
is probably in excess of 100,000 mg~minlrn.~ The acute inhalation toxicity of 
pyrotechnically generated CR is more than pure CR which may be due to the formation 
of other toxic products at higher temperature. Thermolysis studies in this establishment 
shows that CR is quite stable upto 450°C, above 500°C decomposition starts; some 
of the products of decomposition are identified by us are the following: 
The formation of these products can be explained by the following free radical 
mechanism. 
Some of these products, like salicyl aldehyde (2), phenols (5) and o-aminoquinone 
(7) have also been reported in the oxidation of CR with dichlorois~cyanurate.~~ 
Acute toxicity (LD,) studies of CR have also been carried93 out in mice and rats 
by oral, intravenous, intraperitoneal and inhalation routes. The values observed were 
in close agreement with the reported values.85 ~ a h e b ~ ~  et al. and ~ l a r i e %  have studied 
the lung mechanics with variety of imtant compounds and found that inhaled chemicals 
are likely to induce change in the lung surfactant and adversely affect the ventilatory 
function of the lungs. The detailed lung mechanics and pulmonary dynamic surface 
tension with pure aerosol of CR (Concentration 2830 mg/m3) has been camed out in 
rats and it was observed that lungs were free from pulmonary oedema attributable to 
CR inhalation. However, other findings like presence of inflammatory reaction at the 
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level of alveolar septa, mild congestion and increased inflammatory cell in the 
interstitial spaces, small and scattered foci of patchy areas of emphysema were noticed. 
No significant changes in the different of pulmonary mechanics or 
pulmonary dynamic surface tension and in pulmonary phospholipid were observed. 
In animal experiment CR is neither teratogenic nor embryotoxic when given as 
aeros01.~~-~~ All biomedical studies show CR to be a potent sensory irritant with a low 
order of lethal and sub-lethal toxicity. 
5. CONCLUSION 
For nearly eight decades experiments with irritant compounds as weapons in war 
and also in peace-keeping operations are being conducted. The lead for using such 
compounds were probably taken from insects and animals which squirt irritating fluids 
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on an attacker. However, over the years, these compounds found a firm place with 
the police forces in peace-keeping and also with some armies. As they are used in 
war and peace, the tear gases have also become a headache for diplomats in the 
chemical disarmament talks. 
Research has produced a chemical with maximum irritancy or lowest threshold 
concentration, but the least lethality or very large LDm or L(Ct), value. In other 
words, the gap between the two values needed for the safest and the most efficient 
compound is nearly achieved. Dibenz (b,f), [1,4] - oxazepine should be the most 
acceptable chemical today. 
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